ZWZengguo Wang

Zengguo Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zengguo Wang has a total of 59 co-authors. Here are the top co-authors by number of shared publications:

  • Jianfei Shi

    Department of Clinical Laboratory, Xi’an Children’s Hospital, the Affiliated Children’s Hospital of Xi’an Jiaotong University, Xi’an, China

    5 shared publications
  • Wei Wang

    National Regional Children's Medical Center (Northwest), Department of Clinical Laboratory, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an, 710003, Shaanxi, China

    4 shared publications
  • Yang Luan

    Xi’an Center for Disease Control and Prevention, Xi’an, China

    4 shared publications
  • Congcong Chen

    Department of Clinical Laboratory, Xi’an Children’s Hospital, the Affiliated Children’s Hospital of Xi’an Jiaotong University, Xi’an, China

    3 shared publications
  • Kaichong Jiang

    National Regional Children's Medical Center (Northwest), Shaanxi Institute for Pediatric Diseases, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an, 710003, Shaanxi, China

    3 shared publications
  • Peiwen Ning

    Department of Clinical Laboratory, Xi’an Children’s Hospital, the Affiliated Children’s Hospital of Xi’an Jiaotong University, Xi’an, China

    3 shared publications

Latest Publications

  • Epidemic Pattern Changes in Influenza A and B and Mycoplasma pneumoniae Pediatric Respiratory Infections During and After the COVID-19 Pandemic Restrictions in Northwest China

    by Jianyong Tang, Wei He, Bei Li, You Wu, Congcong Chen, Peiwen Ning, Yu Xi, Jianfei Shi, Jiahua Liu, Zengguo Wang

    The COVID-19 pandemic significantly changed respiratory pathogen patterns in children. In this study, we aimed to provide evidence that may help guide prevention and control of pediatric respiratory diseases in the post-pandemic era. Thus, we conducted a retrospective study of children with respiratory symptoms who visited our hospital from January 2020 to December 2024. A total of 169,757 were tested for influenza A (IAV) and B (IBV) antigens, and 412,015 for Mycoplasma pneumoniae (MP) IgM antibodies. Demographic and laboratory data were extracted from electronic medical records and analyzed. We found that from 2020 to 2024, 16,042 children tested positive for IAV, 3,728 for IBV, and 82,760 for MP. Positivity rates varied significantly by year (P < 0.001). During the pandemic, detection rates for IAV, IBV, and MP remained low. After restrictions were lifted, IAV peaked in March 2023 and MP in November 2023. Detection rates for all three pathogens varied significantly by age (P < 0.001) and season (P < 0.001), both during and after the restrictions. Post-restriction age and seasonal patterns for IAV and MP were similar to those during the pandemic, while IBV showed minor shifts. Overall, following relaxation of pandemic measures, influenza viruses and MP resumed epidemic circulation in children. These findings highlight the importance of monitoring respiratory pathogen epidemiology to guide prevention and control in the post-pandemic era.

  • Open Access

    Charcoal agar interference in antibiotic susceptibility testing of Bordetella pertussis: evaluation and alternative methodologies

    by Wei Wang, Lin Wang, Kaichong Jiang, Jianyong Tang, Shuyue Tang, Wenjuan Zhao, Zengguo Wang

    Erythromycin-resistant Bordetella pertussis (ERBP) has increased sharply in China, posing significant challenges to clinical treatment. The lack of a standardized antimicrobial susceptibility testing (AST) system for B. pertussis makes it difficult to screen out effective antibiotics, which further aggravates the generation of drug-resistant strains and causes a vicious cycle. In this study, we modified a superior charcoal-free medium for antibiotic susceptibility testing, enabling more reliable evaluation of antibiotic efficacy. The minimum inhibitory concentrations (MICs) of erythromycin (E), trimethoprim-sulfamethoxazole (TMP-SMX), levofloxacin (LVF), and piperacillin (PIP) were determined using E-test strips on the agar plates with and without charcoal. The performance of these two media for AST was compared to establish a more accurate laboratory detection method. Subsequently, the superior charcoal-free medium was used to assess the antibiotic susceptibility of 98 B. pertussis strains isolated from clinical specimens after the COVID-19 pandemic, analyzing the sensitivity distribution of these first-line and alternative antibiotics. The MIC values of TMP-SMX and LVF were significantly higher on charcoal-containing agar plates than on charcoal-free medium. E-test results revealed that the MICs of B. pertussis strains to TMP-SMX and LVF had increased by approximately five gradient levels on the charcoal-containing agar compared to charcoal-free agar. Quality control (QC) testing demonstrated that the MICs of TMP/SMX and LVX fell outside the acceptable QC range due to adsorption by charcoal particles. Antimicrobial susceptibility of 98 B. pertussis clinical isolates showed that all strains were resistant to E with the MIC90 exceeded the maximum value (> 256 μg/mL). The overall MIC90 values for TMP-SMX, LVF and PIP were 1/0.75/<0.016 μg/mL on charcoal-containing agar and 0.023/0.008/<0.016 μg/mL on charcoal-free medium, respectively. Statistical analysis of violin plots confirmed that the MIC values of the second-line antibiotic TMP-SMX and LVF were significantly elevated on charcoal-containing agar. An accurate AST method can provide crucial guidance for optimal antibiotic selection in patients with B. pertussis infections. Our findings demonstrate that charcoal-free agar serves as an effective alternative medium for reliable AST of B. pertussis clinical isolates. The online version contains supplementary material available at 10.1186/s12941-026-00856-5.

  • Common respiratory virus spectrum and epidemiological trends among children in Northwest China during the post-COVID-19 era

    by You Wu, Weina Yang, Congcong Chen, Jianfei Shi, Peiwen Ning, Jiahua Liu, Rui Wu, Zengguo Wang, Jianyong Tang

    Objective To explore the epidemiology of common pediatric respiratory viruses among children in the post–COVID-19 era. Methods Retrospective analysis of children with respiratory symptoms who visited our hospital between March 2023 and May 2025 was conducted. Influenza A/B (IAV/IBV) antigen testing was performed for 151,809 children; nucleic acid testing for respiratory syncytial virus (RSV), adenovirus (ADV), human metapneumovirus (HMPV), and parainfluenza viruses (PIV) I–III was performed for 35,326 children. Demographic and laboratory data were analyzed. Results Across two post-pandemic seasons, most viruses resurged; HMPV and PIV II peaked more prominently in season 2. RSV showed the highest positivity, whereas IAV had the most positive cases. RSV and PIV III predominated in infants; IAV, HMPV, and PIV I/II predominated in preschoolers; and IBV and ADV predominated in school-aged children. IAV, IBV, and the RSV shared a winter peak and summer trough, whereas the PIV subtypes displayed distinct seasonality. Clinically, IAV and IBV were associated mainly with acute upper respiratory infections; non-severe pneumonia was associated predominantly with RSV, ADV, HMPV, and PIVs. Coinfections were most frequent with ADV and HMPV and least frequent with IAV and IBV; the most common dual and triple coinfections were “RSV + ADV” and “RSV + ADV + IBV”. Conclusion In the post-COVID-19 era, the age distribution, seasonality, and coinfection patterns of pediatric respiratory viruses shifted. Viruses with high detection and coinfection propensities warrant strengthened surveillance and tailored control strategies.

  • Analysis of the value of novel inflammatory indicators derived from complete blood count in predicting for pertussis in children

    by Jianyong Tang, Fang Wu, You Wu, Congcong Chen, Peiwen Ning, Wei Wang, Jianfei Shi, Xingyan Guo, Zengguo Wang

    Objective Inflammatory indicators derived from complete blood count (CBC) have been shown to exhibit substantial clinical utility across a broad spectrum of infectious and inflammatory conditions, this study aimed to explore the potential value of CBC-derived inflammatory indicators in predicting for pertussis in children. Methods CBC parameters of all the participants included in this study were collected. The CBC-derived inflammatory indicators evaluated included the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), [neutrophil + monocyte]-to-lymphocyte ratio (NMLR), systemic immune-inflammation index (SII), and systemic inflammatory response index (SIRI). The predictive value of CBC-derived inflammatory indicators was assessed using the receiver operating characteristic (ROC) curve analysis. Results A total of 892 pertussis children, 903 children with non-pertussis respiratory tract infection and 1,165 healthy children were included in this study. Compared to healthy children, the PLR in children with pertussis was significantly reduced (p < 0.001), whereas the levels of the other indicators were significantly increased. Simultaneously, the indicators in children with pertussis were significantly lower than those in children with non-pertussis infection. In the comparative analysis of inflammatory indicators across different age subgroups, all indicators in the pertussis group were significantly elevated in children < 2 years old, compared to those in both the non-pertussis group and the healthy group; conversely, in children > 2 years old, these indicators were significantly lower than those observed in the non-pertussis group. The ROC analysis results indicated that, aside from PLR, the CBC-derived inflammatory indicators demonstrated significant value in predicting for pertussis infection in children < 2 years old. Furthermore, the integration of multiple markers could enhance diagnostic performance. Conclusion CBC-derived inflammatory indicators, particularly NLR and NMLR, may serve as valuable tools for early predicting for pertussis in children under 2 years old in clinical practice.


  • Open Access

    The whole-cell proteome shows the characteristics of macrolides-resistant Bordetella pertussis in China linked to the biofilm formation

    by Zhe Lv, Sha Yin, Kaichong Jiang, Wei Wang, Yang Luan, Shuang Wu, Jianfei Shi, Zhe Li, Xiao Ma, Zengguo Wang, et al.

    The macrolides-resistant Bordetella pertussis (MR-Bp) isolates in China evolved from the ptxP1/fhaB3 allele and rapidly became predominant, suggestive of an adaptive transmission ability. This was different from the global prevalent ptxP3 strains, in which MR-Bp was rarely reported. The study aimed to determine the underlying mechanism responsible for fitness and resistance in these two strains. We identify proteomic differences between ptxP1/fhaB3 and ptxP3/fhaB1 strains using tandem mass tag (TMT)-based proteomics. We then performed in-depth bioinformatic analysis to determine differentially expressed genes (DEGs), followed by gene ontology (GO), and protein–protein interaction (PPI) network analysis. Further parallel reaction monitoring (PRM) analysis confirmed the expression of four target proteins. Finally, the crystal violet method was used to determine biofilm-forming ability. The results showed that the main significantly different proteins between the two represent isolates were related to biofilm formation. Furthermore, we have confirmed that ptxP1/fhaB3 showed hyperbiofilm formation in comparison with ptxP3/fhaB1. It is suggested that the resistance and adaptability of ptxP1/fhaB3 strains may be related to the formation of biofilm through proteomics. In a word, we determined the significantly different proteins between the ptxP1/fhaB3 and ptxP3/fhaB1 strains through whole-cell proteome, which were related to biofilm formation.


  • Open Access

    The whole-cell proteome shows the characteristics of macrolides-resistant Bordetella pertussis in China linked to the biofilm formation

    by Zhe Lv, Sha Yin, Kaichong Jiang, Wei Wang, Yang Luan, Shuang Wu, Jianfei Shi, Zhe Li, Xiao Ma, Zengguo Wang, et al.

    The macrolides-resistant Bordetella pertussis (MR-Bp) isolates in China evolved from the ptxP1/fhaB3 allele and rapidly became predominant, suggestive of an adaptive transmission ability. This was different from the global prevalent ptxP3 strains, in which MR-Bp was rarely reported. The study aimed to determine the underlying mechanism responsible for fitness and resistance in these two strains. We identify proteomic differences between ptxP1/fhaB3 and ptxP3/fhaB1 strains using TMT-based proteomics. We then performed in-depth bioinformatic analysis to determine differentially expressed genes (DEGs), followed by gene ontology (GO), and protein-protein interaction (PPI) network analysis. Further PRM analysis confirmed the expression of 4 target proteins. Finally, the crystal violet method was used to determine biofilm-forming ability. The results showed that the main significant different proteins between the two represent isolates were related to biofilm formation. Furthermore, we have confirmed that ptxP1/fhaB3 showed hyperbiofilm formation in comparison with ptxP3/fhaB1. It is suggested that the resistance and adaptability of ptxP1/fhaB3 strains may be related to the formation of biofilm through proteomics. In a word, we determined the significantly different proteins between the ptxP1/fhaB3 and ptxP3/fhaB1 strains through whole-cell proteome, which were related to biofilm formation.

    • 1 January 2022
      • Vol. 14  (3) , 1765-1777

    Mediator complex subunit 8 is a prognostic biomarker in hepatocellular carcinoma

    by Shuang Wu, Qiao Li, Yuan Cao, Senyuan Luo, Zengguo Wang, Taoyuan Zhang

    Background: Mediator complex subunit 8 (MED8) is known for its role in encoding a subunit of the mediator complex (MED), that is critical for transcription. MED8 is significantly expressed in various tumors and has been correlated with an unfavorable prognosis. Nevertheless, no relationships have been found between MED8 and the clinical characteristics of hepatocellular carcinoma (HCC). Methods: To conduct an evaluation of correlations between clinicopathologic characteristics and MED8 expression, the logistic regression, Wilcoxon signed-rank test, and Kruskal-Wallis test were used. To perform analysis of factors contributing to prognosis, the Kaplan-Meier approach and the Cox regression analyses were used. A nomogram on the basis of a Cox multivariate analysis was employed to anticipate the influence of MED8 on patient prognosis. The receiver operating characteristic (ROC) curves were plotted and the areas under the curve (AUC) were calculated to assess the prognostic value of MED8. Both immune infiltration analysis and Gene Set Enrichment Analysis (GSEA) were applied to reveal significant enrichment differences among TCGA data. Quantitative RT-PCR (qRT-PCR) and western blotting were used to verify the difference in the expression of MED8 in normal and hepatocellular carcinoma cells. The immunohistochemical method was used to validate the MED8 expression in tumor and adjoining tissues of HCC patients. Results: A univariate analysis showed that high MED8 expression predicts poor disease-specific survival (DSS) (HR: 2.57; 95% confidence interval (CI) 1.62, 4.07; P<0.001). Multivariate regression analysis showed that high MED8 (adjusted HR: 3.032 (1.817, 5.060); P<0.001) expression and M stage (adjusted HR=4.075 (1.179-14.091) for M1 vs. MO, P=0.026) served as prognostic indicators of unfavorable overall survival in an independent manner in patients with HCC. The C-index for the nomogram was 0.732 (95% CI: 0.698, 0.766) and the AUC of MED8 was 0.817 (95% CI: 0.778, 0.857). Functional analysis showed that the cell cycle checkpoints, p53 dependent G1-DNA damage response, mitotic G1-G1-S phases, and mitotic G2-G2-M phases, were significantly enriched in DEGs associated with MED8 expression. Th2 cells were positively correlated with MED8 expression. Conclusions: MED8 predicts poor prognosis in HCC, possibly through modulating the cell cycle and Th2 cells.


  • Open Access

    The global prevalence ptxP3 lineage of Bordetella pertussis was rare in young children with the co-purified aPV vaccination: a 5 years retrospective study

    by Zengguo Wang, Yang Luan, Quanli Du, Chang Shu, Xiaokang Peng, Huijing Wei, Tiejun Hou, Ying Liu, Xiaoguai Liu, Yarong Li

    Background: The global prevalent ptxP3 strains varies from about 10% to about 50% of circulating B. pertussis population in different areas of China. Methods: To investigate the difference of vaccination status between different genotypes in the circulating B. pertussis after 10 years of acellular pertussis vaccine (aPV) used in China. The nasopharyngeal swabs and isolates of B. pertussis from these patients were used to perform genotyping of antigen genes. We use antibiotic susceptibility test against erythromycin and sequencing methods for site 2047 of 23S rRNA to determine the resistance status. Results: The ptxP1 allele with erythromycin resistant (ER) B. pertussis infection (total of 449 subjects) consisted of 84.70 to 96.70% from 2012 to 2016 in this study. Vaccinated with co-purified aPV was found in 133(133/403,33.0%), 1(1/9,11.1%) and 2(2/21,9.5%) in ptxP1/fhaB3-ER, ptxP1/fhaB2-ES and ptxP3/fhaB2-ES B. pertussis infected children each, which showed a significant difference (χ2 = 6.87, P = 0.032). Conclusions: The ptxP3-ES B. pertussis was rare while the ptxP1-ER B. pertussis was steadily increased in Xi’an, China from 2012 to 2016, where co-purified aPV was prevalent used. This pose a hypothesis that the co-purified aPV might protect against ptxP3 strains more efficient, which generated a rare chance for ptxP3 strains to be under the antibiotic pressure and further developed to be erythromycin resistance. A further cohort study and the mechanisms of the additional antigen proteins of co-purified aPV protected against B. pertussis should be consideration.


  • Open Access

    The global prevalence ptxP3 lineage of Bordetella pertussis was rare in young Children with the Co-purified aPV vaccination: a 5 years retrospective study

    by Zengguo Wang, Yang Luan, Quanli Du, Chang Shu, Xiaokang Peng, Huijing Wei, Tiejun Hou, Ying Liu, Xiaoguai Liu, Yarong Li

    Background: The global prevalent ptxP3 strains varies from about 10% to about 50% of circulating B. pertussis population in different areas of China. Methods To investigate the difference of vaccination status between different genotypes in the circulating B. pertussis after 10 years of acellular pertussis vaccine (aPV) used in China. The nasopharyngeal swabs and isolates of B. pertussis from these patients were used to perform genotyping of antigen genes. We use antibiotic susceptibility test against erythromycin and sequencing methods for site 2047 of 23S rRNA to determine the resistance status. Results The ptxP1 allele with erythromycin resistant strains infection (total of 449 samples) consisted of 84.70% to 96.70% from 2012 to 2016. Only 2 of the 21 ptxP3 strains infected in children vaccinated with co-purified aPV, that showed a significant difference between the ptxP1 strains does (χ 2 =6.87, P=0.032). Conclusions The ptxP1 allele with erythromycin resistant B. pertussis was steadily increased in Xi’an, China from 2012 to 2016, where co-purified aPV was prevalence used . We assumed that the co-purified aPV might protect against ptxP3 strains more efficient, which generated a rare chance for ptxP3 strains to be under the antibiotic pressure and further developed to be erythromycin resistance. A further cohort study and the mechanisms of the additional antigen proteins of co-purified aPV protected against B. pertussis should be consideration.